Business Description
Benitec Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : AU000000BLT8
Description
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 321.52 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 5/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -67.8 | |||||
| 3-Year EBITDA Growth Rate | 53.2 | |||||
| 3-Year EPS without NRI Growth Rate | 53.4 | |||||
| 3-Year FCF Growth Rate | 53.2 | |||||
| 3-Year Book Growth Rate | -90.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 79.23 | |||||
| 9-Day RSI | 55.86 | |||||
| 14-Day RSI | 50 | |||||
| 6-1 Month Momentum % | -40 | |||||
| 12-1 Month Momentum % | -78.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.01 | |||||
| Quick Ratio | 15.01 | |||||
| Cash Ratio | 14.9 | |||||
| Days Payable | 526768 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -193.4 | |||||
| Shareholder Yield % | -27.48 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -64.89 | |||||
| ROA % | -56.55 | |||||
| ROIC % | -1690.07 | |||||
| ROC (Joel Greenblatt) % | -4796.61 | |||||
| ROCE % | -69.27 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 186.85 | |||||
| PB Ratio | 2.81 | |||||
| Price-to-Tangible-Book | 3 | |||||
| EV-to-EBIT | -7.46 | |||||
| EV-to-EBITDA | -7.58 | |||||
| EV-to-Revenue | 2221.65 | |||||
| EV-to-FCF | -8.58 | |||||
| Price-to-Net-Current-Asset-Value | 3 | |||||
| Price-to-Net-Cash | 3 | |||||
| Earnings Yield (Greenblatt) % | -13.4 | |||||
| FCF Yield % | -8.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Benitec Biopharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | 0 | ||
| Beta | 0 | ||
| Volatility % | 82.43 | ||
| 14-Day RSI | 50 | ||
| 14-Day ATR (A$) | 0 | ||
| 20-Day SMA (A$) | 0.028 | ||
| 12-1 Month Momentum % | -78.57 | ||
| 52-Week Range (A$) | 0.02 - 0.15 | ||
| Shares Outstanding (Mil) | 321.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Benitec Biopharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Benitec Biopharma Inc Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Benitec Biopharma Inc Frequently Asked Questions
What is Benitec Biopharma Inc(ASX:BLT)'s stock price today?
The current price of ASX:BLT is A$0.03. The 52 week high of ASX:BLT is A$0.15 and 52 week low is A$0.02.
When is next earnings date of Benitec Biopharma Inc(ASX:BLT)?
The next earnings date of Benitec Biopharma Inc(ASX:BLT) is 2025-02-13 Est..
Does Benitec Biopharma Inc(ASX:BLT) pay dividends? If so, how much?
Benitec Biopharma Inc(ASX:BLT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers